A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

NCT07532746 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
55
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Kousai Bio Co., Ltd.